The MIGAL Galilee Research Institute will begin clinical trials on humans as part of the development of a vaccine for the novel coronavirus, Channel 12 News reported on Sunday.
According to the report, the research institute has successfully completed the animal testing phase and is headed towards conducting tests on humans.
Read more